Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma
Clinical trial NCT06448026 · RECRUITING
Trial details
- NCT number
- NCT06448026
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-21
- Primary completion
- 2027-05-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.